Cemented Hemiarthroplasty Versus Uncemented Furlong Hemiarthroplasty
Hip Fractures
About this trial
This is an interventional treatment trial for Hip Fractures
Eligibility Criteria
Inclusion Criteria:
- All patients admitted to Peterborough City Hospital with a displaced intracapsular fracture will be considered for inclusion in the study.
Exclusion Criteria:
• Younger patients in which internal fixation is felt to be the choice of treatment to preserve the femoral head. This is generally those aged less than 60 years in which these patient have an expected good long term survival and are all treated by reduction and internal fixation.
- All other patients in whom the injury is to be treated by reduction and internal fixation for a specific indication.
- Those patients who are able to walk independently out of doors with no more than the use of a stick and are not cognitively impaired. These patients will first be considered for the ongoing randomised trial of Hemiarthroplasty or Total hip replacement (R&D reference - R&D/2012/30, REC reference - 12/LO/15490)
- Patients who decline to participate.
- Patients admitted when MJP is not available to supervise treatment.
Sites / Locations
- Peterborough and Stamford Hospital NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Cemented monoblock hemiarthroplasty
Hyroxyapatite coated prosthesis
The cemented monoblock hemiarthroplasty is a double tapered polished stem with a hemiarthroplasty head cemented in place (Zimmer incorporated, UK)
the Furlong Hyroxyapatite coated prosthesis (JRI orthopaedics limited UK) is a hydroxyapatite coating uncemented a hip prosthesis with a hemiarthroplasty head. The implant is uncemented.